Vagifem 10mcg approved for atrophic vaginitis due to menopause - MPR
Links shared publicly online about this topic.
- 1,557total visits
Vagifem 10mcg approved for atrophic vaginitis due to menopause - MPR
empr.com —
View full resource at empr.com
Tags: Menopause, Vaginal Infection, Women's Health, FDA, Estring, Novo Nordisk, Estrogen in the Body, Estradiol
Most Recently Shared on December 3, 2009 at 4:58 pm By:
MPR News: Vagifem 10mcg approved for atrophic vaginitis due to menopause: The FDA has approved a 10mcg formulation ... http://bit.ly/63e21J
Vagifem 25mcg to be discontinued - ONA
oncologynurseadvisor.com — “Novo Nordisk announced that Vagifem (estradiol hemihydrate vaginal tablets) 10mcg will become the only available formulation of Vagifem for the treatment of atrophic vaginitis. This action is in accordance with medical recommendations for women to use the lower effective estrogen dose to treat the symptoms of atrophic vaginitis due to menopause.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 20, 2010 at 3:23 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Vagifem 25mcg to be discontinued http://goo.gl/fb/iDNoO
FDA Approves 10 mcg Dose of Vagifem for the Treatment of Atrophic Vaginitis Due to Menopause
drugs.com — “Vagifem (estradiol vaginal tablets) is used to treat atrophic vaginitis. Includes Vagifem side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on December 2, 2009 at 11:33 pm By:
FDA Approves 10 mcg Dose of Vagifem for the Treatment of Atrophic Vaginitis Due to Menopause - http://bit.ly/4xvEUQ
Advertisement
